{"id":755267,"date":"2023-05-04T17:46:10","date_gmt":"2023-05-04T21:46:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/"},"modified":"2023-05-04T17:46:10","modified_gmt":"2023-05-04T21:46:10","slug":"eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/","title":{"rendered":"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023"},"content":{"rendered":"<h2>\nManagement to host conference call and webcast at 4:30 p.m. ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"justify\">IRVINE, Calif., May  04, 2023  (GLOBE NEWSWIRE) &#8212; Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (NASDAQ: ELDN) today announced that it plans to release financial results for the first quarter ended\u00a0March 31, 2023\u00a0on\u00a0Thursday, May 11, after the close of trading. Eledon\u2019s management team will host a conference call and webcast beginning at\u00a04:30 p.m. ET.<\/p>\n<p>\n        <strong>Conference Call and Webcast Details:<\/strong>\n      <\/p>\n<p>Thursday, May 11, 2023\u00a0at\u00a04:30 p.m. Eastern Time\u00a0\/\u00a01:30 p.m. Pacific Time<br \/>Toll Free: 888-886-7786<br \/>International: 416-764-8658<br \/>Conference ID: 11107025<br \/>Webcast:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-qgQzOL8cba7dVZz0ZMBhdIM7BhRUGYcXsqjVdWRlwBrLUyEvSEiWxW2b5KkIJEruPLNNoeQnuWRw1g1KhpNmc76wW8L9V9wYILhsWH2UwjdhPuRZ_hYD17OnCCpKXWEaF3lDf7XjirEnkZOEwgsZHAZp15PzKUBFTAEHoyM6B4=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.eledon.com\/events-and-presentations\/events<\/a><\/p>\n<p>After the live webcast, the event will be archived on Eledon\u2019s website for one year.<\/p>\n<p>\n        <strong>About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501) <\/strong>\n      <\/p>\n<p align=\"justify\">Eledon Pharmaceuticals is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS. The company\u2019s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, CA. For more information, please visit the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F2zENekfdTl8uIYqCNN2X-KaTtPKCYmNmx6qxuUiFSdYWKLSVyeZti2_znQoA8HfEx2bgVipv5ewxhWf1RskTg==\" rel=\"nofollow noopener\" target=\"_blank\">www.eledon.com<\/a>.<\/p>\n<p>Follow Eledon Pharmaceuticals on social media: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nEZLgVyLwcwAFVJMv192zDmWQGp8TI-XiuVadJeZHq9VTA5LYlsFI9NKpCzNzfGTHu7qJj1n-wDDIvmgeEwpM6utmnSS0t8_AUbx_HYES_mWz4ztKfvYHea7pRBtj2iEvoBUfPAgaUaWe0aVwr4dQYcWZx6TlFYy9ENNUeSsNAilwsNW6sh77sxvXqaI8roYppqlbsOs0Yj3OARVh-8k2zzydUz_It1zuMTv0yREvZqgPZ_4-9UywrNOKpG_zND7\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pUA8suiLolIvhW8CrBCEI4bYn6ukbQLyHZaPf2L3nBQSNmXjUO_-t4_ctvl_jSmKqCOtC9r6n0CUmcEzufn9XmMEyUWJGXfJSkRbYmqHon4_WeSgmIicIL3WKQ4nsgBF-oxuP_MQtbDGSe_L45F5hliB4tnchomwsqPKu96xj-W68fHbt2YhqQqb5782eq1cqcym9NkNbZjChLV52JYCQA==\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>Stephen Jasper <br \/>Gilmartin Group <br \/>(858) 525-2047 <br \/>stephen@gilmartinir.com<\/p>\n<p>Source: Eledon Pharmaceuticals<\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NmNkYjQwYjEtYjMyMS00OTgwLThiODEtY2RhNWNkNzhjNGQ0LTEwMTgxMjM=\/tiny\/Eledon-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Management to host conference call and webcast at 4:30 p.m. ET IRVINE, Calif., May 04, 2023 (GLOBE NEWSWIRE) &#8212; Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (NASDAQ: ELDN) today announced that it plans to release financial results for the first quarter ended\u00a0March 31, 2023\u00a0on\u00a0Thursday, May 11, after the close of trading. Eledon\u2019s management team will host a conference call and webcast beginning at\u00a04:30 p.m. ET. Conference Call and Webcast Details: Thursday, May 11, 2023\u00a0at\u00a04:30 p.m. Eastern Time\u00a0\/\u00a01:30 p.m. Pacific TimeToll Free: 888-886-7786International: 416-764-8658Conference ID: 11107025Webcast:\u00a0https:\/\/ir.eledon.com\/events-and-presentations\/events After the live webcast, the event will be archived on Eledon\u2019s website for one year. About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501) Eledon Pharmaceuticals is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755267","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Management to host conference call and webcast at 4:30 p.m. ET IRVINE, Calif., May 04, 2023 (GLOBE NEWSWIRE) &#8212; Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (NASDAQ: ELDN) today announced that it plans to release financial results for the first quarter ended\u00a0March 31, 2023\u00a0on\u00a0Thursday, May 11, after the close of trading. Eledon\u2019s management team will host a conference call and webcast beginning at\u00a04:30 p.m. ET. Conference Call and Webcast Details: Thursday, May 11, 2023\u00a0at\u00a04:30 p.m. Eastern Time\u00a0\/\u00a01:30 p.m. Pacific TimeToll Free: 888-886-7786International: 416-764-8658Conference ID: 11107025Webcast:\u00a0https:\/\/ir.eledon.com\/events-and-presentations\/events After the live webcast, the event will be archived on Eledon\u2019s website for one year. About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501) Eledon Pharmaceuticals is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 &hellip; Continue reading &quot;Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T21:46:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023\",\"datePublished\":\"2023-05-04T21:46:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/\"},\"wordCount\":231,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/\",\"name\":\"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=\",\"datePublished\":\"2023-05-04T21:46:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/","og_locale":"en_US","og_type":"article","og_title":"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Market Newsdesk","og_description":"Management to host conference call and webcast at 4:30 p.m. ET IRVINE, Calif., May 04, 2023 (GLOBE NEWSWIRE) &#8212; Eledon Pharmaceuticals, Inc. (\u201cEledon\u201d) (NASDAQ: ELDN) today announced that it plans to release financial results for the first quarter ended\u00a0March 31, 2023\u00a0on\u00a0Thursday, May 11, after the close of trading. Eledon\u2019s management team will host a conference call and webcast beginning at\u00a04:30 p.m. ET. Conference Call and Webcast Details: Thursday, May 11, 2023\u00a0at\u00a04:30 p.m. Eastern Time\u00a0\/\u00a01:30 p.m. Pacific TimeToll Free: 888-886-7786International: 416-764-8658Conference ID: 11107025Webcast:\u00a0https:\/\/ir.eledon.com\/events-and-presentations\/events After the live webcast, the event will be archived on Eledon\u2019s website for one year. About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501) Eledon Pharmaceuticals is a clinical stage biotechnology company using its immunology expertise in targeting the CD40 &hellip; Continue reading \"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T21:46:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023","datePublished":"2023-05-04T21:46:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/"},"wordCount":231,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/","name":"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=","datePublished":"2023-05-04T21:46:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMjUyMCM1NTc2MzkzIzIwMDY1NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eledon-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-thursday-may-11-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755267"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755267\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}